Drug Development

Drug development studies are extremely expensive, costing billions of dollars and taking up to 10 years to bring a drug to market.

With the advent of next generation sequencing (NGS), the human genome can now be sequenced in a short time with a low cost and therefore provide an extremely valuable tool for drug development studies.  Utilizing this technology, early target identification can be hastened, new genetic lesions associated with the disease can be found, and overall development times associated with therapeutics and diagnostics to newly identified targets can be significantly shortened.

Quick Biology has the right expertise to help shape your drug development projects - providing the most streamlined study protocols to answer the important questions, thus enables the study to proceed down the drug or diagnostic development chain efficiently.

NGS service quote request, click here!